Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

Drug Maker to Settle Kickback, Off-Label Allegations for $41M

Kos Pharmaceuticals, a subsidiary of Abbott Laboratories, will pay more than $41 million to resolve criminal and civil False Claims Act violations related to illegal kickbacks and off-label marketing for two cholesterol drugs, the U.S. Justice Department has announced.

Please enter your comment below:
Please enter the text below: